# Hypervalent iodine mediated cyclization of bishomoallylamides to prolinols

Smaher E Butt, Konrad Kepski, Jean-Marc Sotiropoulos, Wesley J Moran

► To cite this version:

Smaher E Butt, Konrad Kepski, Jean-Marc Sotiropoulos, Wesley J Moran. Hypervalent iodine mediated cyclization of bishomoallylamides to prolinols. Beilstein Journal of Organic Chemistry, 2024, 20, pp.2455 - 2460. 10.3762/bjoc.20.209. hal-04734244

HAL Id: hal-04734244

https://univ-pau.hal.science/hal-04734244v1

Submitted on 13 Oct 2024

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

# Hypervalent iodine-mediated cyclization of bishomoallylamides to prolinols

Smaher E. Butt<sup>‡1</sup>, Konrad Kepski<sup>‡1</sup>, Jean-Marc Sotiropoulos<sup>*2</sup> and Wesley J. Moran<sup>*3</sup>

## Full Research Paper

Open Access

Address:
¹Department of Physical and Life Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, United Kingdom,
²Université de Pau et des Pays de l'Adour, IPREM (CNRS-UMR 5254), Technopole Hélioparc, 2 Avenue du Président Pierre Angot, 64053 Pau Cedex 09, France and ³School of Pharmacy and Bioengineering, Keele University, Keele, Staffordshire ST5 5JX, United Kingdom

Email:
Jean-Marc Sotiropoulos* - jean-marc.sotiro@univ-pau.fr;
Wesley J. Moran - w.j.moran@keele.ac.uk

* Corresponding author ‡ Equal contributors

Keywords:
cyclization; DFT; hypervalent iodine; mechanism; proline

Beilstein J. Org. Chem. **2024**, *20*, 2455-2460.
https://doi.org/10.3762/bjoc.20.209

Received: 14 May 2024

Accepted: 13 September 2024

Published: 30 September 2024

This article is part of the thematic issue "Hypervalent halogen chemistry".

Guest Editor: J. Wencel-Delord

<figure><img src="image_3.png" /></figure>

© 2024 Butt et al.; licensee Beilstein-Institut.

License and terms: see end of document.

## Abstract

A change in mechanism was observed in the hypervalent iodine-mediated cyclization of N-alkenylamides when the carbon chain between the alkene and the amide increased from two to three atoms. In the latter case, cyclization at the amide nitrogen to form the pyrrolidine ring was favored over cyclization at the amide oxygen. A DFT study was undertaken to rationalize the change in mechanism of this cyclization process. In addition, reaction conditions were developed, and the scope of this cyclization studied.

## Introduction

Proline is one of the 20 DNA-encoded proteinogenic amino acids that are essential to life [1,2]. In addition, the pyrrolidine core is present in many organocatalysts [3-5], natural products (e.g., the potent α-glucosidase inhibitor (-)-codonopsinol B) [6,7], and pharmaceutical drug molecules such as saxagliptin and ramipril (Figure 1) [8]. Accordingly, the development of methods to access substituted prolines and pyrrolidines is an important area of study as this ring system is prevalent in many useful molecules. Typical literature procedures include multi-step derivations of proline itself, e.g., the destruction of the stereocenter and then its reinstallation by an enantioselective

conjugate addition [9]. Other methods include the enantioselective conjugate addition to α,β-unsaturated pyroglutamic acid derivatives followed by deoxygenation [10], and the enantioselective organocatalytic reaction between 2-acylaminomalonates and α,β-unsaturated aldehydes [11,12].

The development of new synthetic methods using hypervalent iodine reagents has become increasingly popular in recent years probably due to their useful reactivity, ease of handling, and low toxicity [13]. In particular, hypervalent iodine compounds have been shown to be effective reagents and catalysts for a
<figure><img src="image_4.png" /><figcaption>Takemoto's organocatalyst</figcaption></figure>

<figure><img src="image_5.png" /><figcaption>(-)-codonopsinol B</figcaption></figure>

<figure><img src="image_6.png" /><figcaption>saxagliptin
AZ, antidiabetic</figcaption></figure>

<figure><img src="image_7.png" /><figcaption>ramipril
Hoechst AG, antihypertensive</figcaption></figure>

<caption>**Figure 1:** Functional molecules containing a substituted pyrrolidine core.</caption>

range of cyclization reactions [14]. In 2015, we reported the iodoarene-catalyzed cyclization of N-allylamides 1 and N-homoallylamides 2 to 2-oxazolines 4 and dihydrooxazines 5, respectively (Scheme 1A) [15]. We also reported that an N-bishomoallylamide 3 (n = 3) was cyclized under the reaction conditions, but in just 30% yield. It turned out that the product of this reaction was the five-membered prolinol 7a rather than the initially assigned isomeric seven-membered tetrahydro-oxazepine 6 [16]. Subsequently, we set out to understand the O-versus N-chemoselectivity by DFT modelling, and to develop an effective synthetic protocol for the preparation of prolinols 7 in high yield (Scheme 1B). Notably, we are unaware of any reported method to achieve this specific transformation in the literature. Although, Tellitu and co-workers have reported a related preparation of indoline derivatives mediated by bis(trifluoroacetoxy)iodobenzene (PIFA) [17].

## Results and Discussion

In 2019, we reported our DFT study on the cyclization of N-allylbenzamide (1a) to the 2-oxazoline 4a, i.e., where n = 1 and Ar = Ph [18]. This work indicated that the alkene is activated by the iodine(III) species and that this triggers cyclization. Intrigued by the change in mechanism from O- to N-cyclization onto the alkene when n = 3, we modelled this reaction using DFT calculations (Scheme 2). Similarly, we concluded that the present reaction commences with activation of the olefin in 3a by the hypervalent iodine species 8, which is generated under the reaction conditions. The activation occurs via an associative pathway where one of the TFA ligands dissociates from 8 upon approaching the substrate and forms the intermediate 9. The calculated ΔG‡ value is quite high here, which could explain the low yield obtained after 16 hours. However, for the cyclization of N-allylbenzamide (1a), we found that the transition state was stabilized by 4.1 kcal·mol⁻¹ by an extra molecule of trifluoro-

<figure><img src="image_8.png" /><figcaption>A) previous work</figcaption></figure>

<figure><img src="image_9.png" /><figcaption>B) this work</figcaption></figure>

<figure><img src="image_10.png" /><figcaption>**Scheme 1:** A) Our previous report on N-alkenylamide cyclizations.</figcaption></figure>

<caption>B) An overview of the present work.</caption>

acetic acid. A similar stabilizing interaction was not identified in this case with 3a, despite significant effort, but it cannot be ruled out. The cyclization of 9 was shown to be possible by attack of the amide at both the oxygen and the nitrogen, however, the ΔG‡ value for the latter was lower by 2.5 kcal·mol⁻¹. This demonstrates a clear kinetic preference for formation of the five-membered ring over the seven-membered one [19]. Subsequent deprotonation of 11 leads to tertiary amide 12.

Upon cyclization, the iodane moiety in 12 is eliminated by an intramolecular attack by the amide nitrogen to form the aziridinium 13. Finally, ring-opening by S<sub>N</sub>2 attack of trifluoroacetate leads to the final product 14 [20]. In this case, the kinetic pyrrolidine product is obtained due to the electron-withdrawing benzoyl group on the nitrogen atom preventing equilibration to the thermodynamic piperidine product [21]. Basic workup hydrolyzes the trifluoroacetoxy ester in 14 to alcohol 7a. Consideration of the literature NMR data for the three possible isomeric products (i.e., pyrrolidine, piperidine, and tetrahydrooxazepine) as well as DEPT, HSQC, and HMBC data for 7a support the assignment of the pyrrolidine structure.

The next stage of the project was to improve the yield of the reaction. We initiated our study by using our initially developed conditions using 20 mol % 2-iodoanisole and found that the reaction outcome led to variable yields of product in the range of 10–25%. Increasing the quantity of 2-iodoanisole to 150 mol % provided a reproducible 30% yield of 7a (Table 1, entry 1). We then varied the iodoarene to see the impact on the reaction outcome. Using iodobenzene, 2-iodobiphenyl, and
<figure><img src="image_11.png" /><figcaption>**Scheme 2:** Calculated mechanism for the cyclization of amide 3a optimized at the B3LYP/6-31+G(d,p) level of theory with SDDall used for iodine. Solvent effects were considered using the CPCM model. All ΔG values are in kcal·mol⁻¹. Optimized structures are shown for the cyclization transition states (hydrogen atoms are omitted for clarity and bond lengths are given in Å).</figcaption></figure>

3-iodotoluene provided slight improvements in yield (Table 1, entries 2–4). The more electron-rich 2-iodo-1,3-dimethoxybenzene led to a further increase in yield to 44% (Table 1, entry 5). 1,2-Diiodobenzene has been reported to be a superior precatalyst in intermolecular C–H aminations of arenes but only provided 40% yield in the present case [22]. 1-Iodonaphthalene led to an increase in yield to 49% (Table 1, entry 7). 1-Iodo-2,4-dimethoxybenzene afforded the highest yield of all with 59% of tertiary amide being isolated (Table 1, entry 8). Leaving the reaction to stir for an extended period led to a further increase in yield to 68% (Table 1, entry 9). Using the even more electron-

rich 2-iodo-1,3,5-trimethoxybenzene only gave 45% yield (Table 1, entry 10). Our previous studies have shown that the oxidized form of 2-iodo-1,3,5-trimethoxybenzene is unstable in solution and decomposes destructively [18]. Iodoethane was also shown to be an effective reagent furnishing the product in up to 56% upon heating to 40 °C (Table 1, entries 11 and 12). It was envisaged that oxidation of iodoethane led to formation of oxidized forms of iodide by C–I-bond cleavage, therefore tetrabutylammonium iodide was utilized to see if the result could be replicated and it was (Table 1, entry 13). Finally, the reaction was shown to occur using PIFA (bistrifluoroacetoxyiodoben-
<figure><img src="image_12.png" /><figcaption>**Table 1:** Optimization of cyclization reaction.</figcaption></figure>

<table><thead><tr><th>Entry</th><th>Deviation from conditions</th><th>Yield [%]<sup>a</sup></th></tr></thead><tbody><tr><td>1</td><td>none</td><td>30</td></tr><tr><td>2</td><td>iodobenzene</td><td>37</td></tr><tr><td>3</td><td>2-iodobiphenyl</td><td>37</td></tr><tr><td>4</td><td>3-iodotoluene</td><td>39</td></tr><tr><td>5</td><td>2-iodo-1,3-dimethoxybenzene</td><td>44</td></tr><tr><td>6</td><td>1,2-diiodobenzene</td><td>40</td></tr><tr><td>7</td><td>1-iodonaphthalene</td><td>49</td></tr><tr><td>8</td><td>1-iodo-2,4-dimethoxybenzene</td><td>59</td></tr><tr><td>9</td><td>1-iodo-2,4-dimethoxybenzene, 48 h</td><td>68</td></tr><tr><td>10</td><td>2-iodo-1,3,5-trimethoxybenzene</td><td>45</td></tr><tr><td>11</td><td>iodoethane, 40 °C</td><td>38</td></tr><tr><td>12</td><td>iodoethane, 40 °C</td><td>56</td></tr><tr><td>13</td><td>Bu<sub>4</sub>NI</td><td>40</td></tr><tr><td>14</td><td>PIFA, no selectfluor, no TFA</td><td>40</td></tr></tbody></table>

zene), which is envisaged to be produced in the reaction mixture when using iodobenzene as reagent, and a similar yield was obtained (Table 1, entry 14 vs entry 2). The cyclization of amide **3a** did not occur in the absence of an iodine source. Other oxidants, solvents, and acids were screened but superior conditions were not discovered.

With the optimized conditions in hand, the scope of the cyclization was investigated (Scheme 3). We examined the cyclization of *para*-substituted benzamides and chloro- (**7b**), bromo- (**7c**), phenyl- (**7d**), and methoxy- (**7e**) derivatives were all isolated in moderate yields. The *ortho*-substituted derivatives **7f**, **7g**, and **7h** were also successfully prepared. Alkylamides were found to be ambiguous substrates as the acetamide **7i** and pivalamide **7j** were formed in trace quantities whereas the benzyl derivative **7k** was insolable. The enamide **7l** was not observed. Intriguingly, cyclopropyl and cyclohexyl derivatives **7m** and **7n**, respectively, were formed and isolated in moderate yields. Furyl derivative **7o** was isolated in 63% yield. Installing a geminal dimethyl group on the alkyl linker was anticipated to lead to an improvement in cyclization, however, very low conversion was observed and the product **7p** was isolated in 10% yield.

We then investigated the cyclization of *cis*-disubstituted alkene **3q** and were delighted to observe that only one diastereomer of

<figure><img src="image_13.png" /></figure>

**7q** was formed (Scheme 4). This result is in accordance with the calculated mechanism. The more electron-rich trisubstituted alkene **3r** reacted directly with Selectfluor leading to a tertiary carbocation which was trapped by acetonitrile in a Ritter-type process to generate bisamide **15** [23]. As would be expected, one regioisomer and a 1:1 mixture of diastereomers was formed.

<figure><img src="image_14.png" /></figure>

## Conclusion

We have demonstrated that a change in mechanism occurs in the cyclization of *N*-alkenylamides when increasing the chain length between the amide and the alkene. When there are one or two carbon atoms separating the functional groups, cyclization at the amide oxygen occurs to generate five- and six-membered

<footnote><sup>a</sup>The yields are for isolated compounds. TFA = trifluoroacetic acid. PIFA = bis(trifluoroacetoxy)iodobenzene.</footnote>
rings, respectively. However, when there is a three-carbon atom
link, the corresponding seven-membered ring is not formed.
Instead, cyclization at nitrogen occurs to generate a five-mem-
bered ring. We have performed DFT calculations to support the
proposed change in mechanism and developed superior reac-
tion conditions to effect this transformation. Finally, we have
explored the substrate scope of this cyclization.

**Supporting Information**

**Supporting Information File 1**

Experimental procedures, compound characterization data,
copies of NMR spectra, cartesian coordinates and energies
of calculated structures.

[https://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-20-209-S1.pdf]

Acknowledgements

We thank Professor Mark Heron for his useful discussions and
Dr Neil McLay for his NMR expertise. We also acknowledge
Joshua Gauntlett for assistance with synthesis of some interme-
diates.

Funding

This study was supported by an EPSRC Doctoral Training Part-
nership (grant number EP/T51813X/1) held at the University of
Huddersfield (K.K.), a University of Huddersfield funded Ph.D.
studentship (S.B.), and by the Université de Pau et des Pays de
l'Adour for access to their computer cluster.

ORCID® iDs

Jean-Marc Sotiropoulos - https://orcid.org/0000-0001-9513-3639

Wesley J. Moran - https://orcid.org/0000-0002-5768-3629

Data Availability Statement

The data that supports the findings of this study is available from the corre-
sponding author upon reasonable request.

Preprint

A non-peer-reviewed version of this article has been previously published
as a preprint: https://doi.org/10.3762/bxiv.2024.31.v1

References

1. Patriarca, E. J.; Cermola, F.; D'Aniello, C.; Fico, A.; Guardiola, O.; De Cesare, D.; Minchiotti, G. *Front. Cell Dev. Biol.* **2021**, *9*, 728576.
doi:10.3389/fcell.2021.728576

2. Then, A.; Mácha, K.; Ibrahim, B.; Schuster, S. *Sci. Rep.* **2020**, *10*, 15321. doi:10.1038/s41598-020-72174-5

3. Vachan, B. S.; Karuppasamy, M.; Vinoth, P.; Vivek Kumar, S.; Perumal, S.; Sridharan, V.; Menéndez, J. C. *Adv. Synth. Catal.* **2020**, *362*, 87–110. doi:10.1002/adsc.201900558

4. Cobb, A. J. A.; Shaw, D. M.; Longbottom, D. A.; Gold, J. B.; Ley, S. V. *Org. Biomol. Chem.* **2005**, *3*, 84–96. doi:10.1039/b414742a

5. Okino, T.; Hoashi, Y.; Takemoto, Y. *J. Am. Chem. Soc.* **2003**, *125*, 12672–12673. doi:10.1021/ja036972z

6. Mauger, A. B. *J. Nat. Prod.* **1996**, *59*, 1205–1211.
doi:10.1021/np9603479

7. Wakana, D.; Kawahara, N.; Goda, Y. *Chem. Pharm. Bull.* **2013**, *61*, 1315–1317. doi:10.1248/cpb.c13-00516

8. Lenci, E.; Trabocchi, A. *Symmetry* **2019**, *11*, 558.
doi:10.3390/sym11040558

9. Huy, P.; Neudörfl, J.-M.; Schmalz, H.-G. *Org. Lett.* **2011**, *13*, 216–219.
doi:10.1021/ol102613z

10. Perni, R. B.; Farmer, L. J.; Cottrell, K. M.; Court, J. J.; Courtney, L. F.; Deininger, D. D.; Gates, C. A.; Harbeson, S. L.; Kim, J. L.; Lin, C.; Lin, K.; Luong, Y.-P.; Maxwell, J. P.; Murcko, M. A.; Pitlik, J.; Rao, B. G.; Schairer, W. C.; Tung, R. D.; Van Drie, J. H.; Wilson, K.; Thomson, J. A. *Bioorg. Med. Chem. Lett.* **2004**, *14*, 1939–1942.
doi:10.1016/j.bmcl.2004.01.078

11. Rios, R.; Ibrahem, I.; Vesely, J.; Sundén, H.; Córdova, A. *Tetrahedron Lett.* **2007**, *48*, 8695–8699.
doi:10.1016/j.tetlet.2007.10.028

12. Chung, J. Y. L.; Wasicak, J. T.; Arnold, W. A.; May, C. S.; Nadzan, A. M.; Holladay, M. W. *J. Org. Chem.* **1990**, *55*, 270–275.
doi:10.1021/jo00288a045

13. Yoshimura, A.; Zhdankin, V. V. *Chem. Rev.* **2016**, *116*, 3328–3435.
doi:10.1021/acs.chemrev.5b00547

14. Sihag, M.; Soni, R.; Rani, N.; Kinger, M.; Kumar Aneja, D. *Org. Prep. Proced. Int.* **2023**, *55*, 1–62.
doi:10.1080/00304948.2022.2113964

15. Alhalib, A.; Kamouka, S.; Moran, W. J. *J. Org. Lett.* **2015**, *17*, 1453–1456.
doi:10.1021/acs.orglett.5b00333

16. Verbraeken, B.; Hullaert, J.; van Guyse, J.; Van Hecke, K.; Winne, J.; Hoogenboom, R. *J. Am. Chem. Soc.* **2018**, *140*, 17404–17408.
doi:10.1021/jacs.8b10918

17. Correa, A.; Tellitu, I.; Domínguez, E.; SanMartin, R. *J. Org. Chem.* **2006**, *71*, 8316–8319. doi:10.1021/jo061486q

18. Butt, S. E.; Das, M.; Sotiropoulos, J.-M.; Moran, W. J. *J. Org. Chem.* **2019**, *84*, 15605–15613. doi:10.1021/acs.joc.9b02623

19. Casadei, M. A.; Galli, C.; Mandolini, L. *J. Am. Chem. Soc.* **1984**, *106*, 1051–1056. doi:10.1021/ja00316a039

20. O'Brien, P.; Towers, T. D. *J. Org. Chem.* **2002**, *67*, 304–307.
doi:10.1021/jo010824e

21. Hayashi, K.; Kujime, E.; Katayama, H.; Sano, S.; Shiro, M.; Nagao, Y. *Chem. Pharm. Bull.* **2009**, *57*, 1142–1146. doi:10.1248/cpb.57.1142

22. Lucchetti, N.; Scalone, M.; Fantasia, S.; Muñiz, K. *Adv. Synth. Catal.* **2016**, *358*, 2093–2099. doi:10.1002/adsc.201600191

23. Stavber, S.; Pecan, T. S.; Papež, M.; Zupan, M. *Chem. Commun.* **1996**, 2247–2248. doi:10.1039/cc9960002247
License and Terms

This is an open access article licensed under the terms of
the Beilstein-Institut Open Access License Agreement
([https://www.beilstein-journals.org/bjoc/terms](https://www.beilstein-journals.org/bjoc/terms)), which is
identical to the Creative Commons Attribution 4.0
International License
([https://creativecommons.org/licenses/by/4.0](https://creativecommons.org/licenses/by/4.0)). The reuse of
material under this license requires that the author(s),
source and license are credited. Third-party material in this
article could be subject to other licenses (typically indicated
in the credit line), and in this case, users are required to
obtain permission from the license holder to reuse the
material.

The definitive version of this article is the electronic one
which can be found at:
[https://doi.org/10.3762/bjoc.20.209](https://doi.org/10.3762/bjoc.20.209)